Concepedia

Stewart Bieler

SB

Statistics

Publications

5

Citations

587

H-Index

5

Active since

1999

Affiliations

University of Groningen(Current)

UNSW Sydney

University of Washington

Hospital Británico de Buenos Aires

Universidade de São Paulo

Stewart Bieler is an author at University of Groningen specializing in medicine, pulmonary disease, and chronic kidney disease.

Top concepts

Publications per year

1999–2023

5

Publications

5

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

, , +9

Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis

Michelle N. Rheault, Charles E. Alpers, Jonathan Barratt et al. · New England Journal of Medicine · 2023 · 94 citations

Comparative Efficacy and Safety of Albuterol Sulfate Spiros Inhaler and Albuterol Metered-Dose Inhaler in Asthma

Harold S. Nelson, James P. Kemp, Stewart Bieler et al. · CHEST Journal · 1999 · 38 citations

, , +5

IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study

Jonathan Barratt, Brad H. Rovin, Muh Geot Wong et al. · Kidney International Reports · 2023 · 28 citations · Full text

1–5 of 5